Unknown

Dataset Information

0

COVID-19's Radiologic, Functional, and Serologic Consequences at 6-Month and 18-Month Follow-up: A Prospective Cohort Study.


ABSTRACT:

Background

We evaluated the radiologic, pulmonary functional, and antibody statuses of coronavirus disease 2019 (COVID-19) patients 6 and 18 months after discharge, comparing changes in status and focusing on risk factors for residual computed tomography (CT) abnormalities.

Methods

This prospective cohort study was conducted on COVID-19 patients discharged between April 2020 and January 2021. Chest CT, pulmonary function testing (PFT), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) measurements were performed 6 and 18 months after discharge. We evaluated factors associated with residual CT abnormalities and the correlation between lesion volume in CT (lesionvolume), PFT, and IgG levels.

Results

This study included 68 and 42 participants evaluated 6 and 18 months, respectively, after hospitalizations for COVID-19. CT abnormalities were noted in 22 participants (32.4%) at 6 months and 13 participants (31.0%) at 18 months. Lesionvolume was significantly lower at 18 months than 6 months (P < 0.001). Patients with CT abnormalities at 6 months showed lower forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC), and patients with CT abnormalities at 18 months exhibited lower FVC. FVC significantly improved between 6 and 18 months of follow-up (all P < 0.0001). SARS-CoV-2 IgG levels were significantly higher in patients with CT abnormalities at 6 and 18 months (P < 0.001). At 18-month follow-up assessments, age was associated with CT abnormalities (odds ratio, 1.17; 95% confidence interval, 1.03-1.32; P = 0.01), and lesionvolume showed a positive correlation with IgG level (r = 0.643, P < 0.001).

Conclusion

At 18-month follow-up assessments, 31.0% of participants exhibited residual CT abnormalities. Age and higher SARS-CoV-2 IgG levels were significant predictors, and FVC was related to abnormal CT findings at 18 months. Lesionvolume and FVC improved between 6 and 18 months.

Trial registration

Clinical Research Information Service Identifier: KCT0008573.

SUBMITTER: Kim C 

PROVIDER: S-EPMC11333807 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

COVID-19's Radiologic, Functional, and Serologic Consequences at 6-Month and 18-Month Follow-up: A Prospective Cohort Study.

Kim Cherry C   Seok Hyeri H   Kim Jooyun J   Park Dae Won DW   van Assen Marly M   De Cecco Carlo N CN   Choi Hangseok H   Kim Chohee C   Hwang Sung Ho SH   Yong Hwan Seok HS   Oh Yu-Whan YW   Choi Won Suk WS  

Journal of Korean medical science 20240819 32


<h4>Background</h4>We evaluated the radiologic, pulmonary functional, and antibody statuses of coronavirus disease 2019 (COVID-19) patients 6 and 18 months after discharge, comparing changes in status and focusing on risk factors for residual computed tomography (CT) abnormalities.<h4>Methods</h4>This prospective cohort study was conducted on COVID-19 patients discharged between April 2020 and January 2021. Chest CT, pulmonary function testing (PFT), and severe acute respiratory syndrome coronav  ...[more]

Similar Datasets

| S-EPMC10773417 | biostudies-literature
| S-EPMC10651362 | biostudies-literature
| S-EPMC9500865 | biostudies-literature
| S-EPMC4309014 | biostudies-literature
| S-EPMC8794109 | biostudies-literature
| S-EPMC9082048 | biostudies-literature
| S-EPMC8381442 | biostudies-literature
| S-EPMC3533799 | biostudies-literature
| S-EPMC2693729 | biostudies-other
| S-EPMC1725976 | biostudies-literature